Finance

Lists
500420:BOM
Torrent Pharmaceuticals Ltd
₹4 560,00
-1,00%
(-45,95) 1D
16 Okt., 15:57:43 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500420...
Open
₹4 579,80
High
₹4 619,10
Low
₹4 554,00
Mkt. cap
1,54 bn
Avg. vol.
9,70 k
Volume
2,90 k
Dividend
0,83%
Quarterly dividend
₹9,50
Ex-dividend date
29 Mei 2026
P/E ratio
72,84
52-wk high
₹5 249,95
52-wk low
₹3 511,00
EPS
₹62,60
Shares outstanding
170,00 m
No. of employees
18 k
Open
₹4 579,80
High
₹4 619,10
Low
₹4 554,00
Mkt. cap
1,54 bn
Avg. vol.
9,70 k
Volume
2,90 k
Dividend
0,83%
Quarterly dividend
₹9,50
Ex-dividend date
29 Mei 2026
P/E ratio
72,84
52-wk high
₹5 249,95
52-wk low
₹3 511,00
EPS
₹62,60
Shares outstanding
170,00 m
No. of employees
18 k
News stories
From web sources and news partners
Profile
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
About Torrent Pharmaceuticals Ltd
CEO-
Employees18,3 k
Founded1959
HeadquartersAhmedabad, Gujarat, Indië
SectorPharmaceutical industry
Websitetorrentpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
33,02 mjd
33,03 mjd
41,97 mjd
49,21 mjd
Cost of goods sold
8,00 mjd
7,99 mjd
10,15 mjd
11,63 mjd
Cost of revenue
8,00 mjd
7,99 mjd
10,15 mjd
11,63 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,27 mjd
6,51 mjd
8,48 mjd
8,93 mjd
Operating expense
16,23 mjd
16,22 mjd
23,34 mjd
26,87 mjd
Total operating expenses
24,23 mjd
24,21 mjd
33,49 mjd
38,50 mjd
Operating income
8,79 mjd
8,82 mjd
8,48 mjd
10,71 mjd
Other non operating income
-270,00 m
-130,00 m
794,40 m
-120,00 m
EBT including unusual items
7,91 mjd
8,14 mjd
5,29 mjd
7,33 mjd
EBT excluding unusual items
8,04 mjd
8,24 mjd
5,47 mjd
7,54 mjd
Income tax expense
2,00 mjd
1,79 mjd
1,65 mjd
1,67 mjd
Effective tax rate
25,28%
21,99%
31,18%
22,78%
Other operating expenses
7,92 mjd
7,65 mjd
9,78 mjd
12,01 mjd
Net income
5,91 mjd
6,35 mjd
3,89 mjd
5,66 mjd
Net profit margin
17,90%
19,22%
9,28%
11,50%
Earnings per share
17,75
19,00
12,85
15,30
Interest and investment income
-
-
384,30 m
-
Interest expense
-480,00 m
-450,00 m
-2,36 mjd
-3,05 mjd
Net interest expenses
-480,00 m
-450,00 m
-1,97 mjd
-3,05 mjd
Depreciation and amortization charges
2,04 mjd
2,06 mjd
5,08 mjd
5,93 mjd
EBITDA
10,82 mjd
10,69 mjd
11,12 mjd
13,35 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme